Patents by Inventor Asaf KROLL

Asaf KROLL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240108577
    Abstract: This application relates to methods of delivering via inhalation from a source material both pharmacologically-effective doses and placebo doses
    Type: Application
    Filed: October 11, 2023
    Publication date: April 4, 2024
    Applicant: Syqe Medical Ltd.
    Inventors: Ilana ZAKS BOHBOT, Joshua AVIRAM, Asaf KROLL, Anna FRENKLAKH, Roee LIFSHITZ, Daniella ATZMONY
  • Publication number: 20220183962
    Abstract: A dose unit including at least one isolated bioactive agent applied on a carrier material in thermal contact with an electrically heating element configured to vaporize a pre-determined amount of the agent for pulmonary delivery thereof is provided herein, as well as devices for effecting vaporization and pulmonary delivery of the isolated agent, and methods for preparing the dose unit, controllably releasing the agent therefrom, methods for pulmonary delivery thereof and methods of treatment of medical conditions treatable by pulmonary delivery of the isolated bioactive agent.
    Type: Application
    Filed: March 2, 2022
    Publication date: June 16, 2022
    Applicant: Syqe Medical Ltd.
    Inventors: Perry Davidson, Aaron Schorr, Asaf Kroll, Binyamin Schwartz
  • Patent number: 11311480
    Abstract: A dose unit including at least one isolated bioactive agent applied on a carrier material in thermal contact with an electrically heating element configured to vaporize a pre-determined amount of the agent for pulmonary delivery thereof is provided herein, as well as devices for effecting vaporization and pulmonary delivery of the isolated agent, and methods for preparing the dose unit, controllably releasing the agent therefrom, methods for pulmonary delivery thereof and methods of treatment of medical conditions treatable by pulmonary delivery of the isolated bioactive agent.
    Type: Grant
    Filed: August 6, 2018
    Date of Patent: April 26, 2022
    Assignee: Syqe Medical Ltd.
    Inventors: Perry Davidson, Aaron Schorr, Asaf Kroll, Binyamin Schwartz
  • Publication number: 20210023316
    Abstract: Some embodiments relate to a method for providing, during a single inhalation from an inhaler, a controllable ratio between at least a first active substance and a second active substance provided from the same source material, comprising: defining a ratio between the first and second active substances to be delivered to a user; setting operation parameters in accordance with the ratio, the operation parameters including at least one of a heating profile of the source material and an airflow profile through the source material; and operating the inhaler according to the operation parameters to deliver to the user, during a single inhalation, at least the first and second active substances at the defined ratio.
    Type: Application
    Filed: February 14, 2019
    Publication date: January 28, 2021
    Applicant: Syqe Medical Ltd.
    Inventors: Aaron SCHORR, Tal LUPO, Asaf KROLL, Binyamin SCHWARTZ, Nimrod RESHEF, Daniella ATZMONY
  • Publication number: 20180344954
    Abstract: A dose unit including at least one isolated bioactive agent applied on a carrier material in thermal contact with an electrically heating element configured to vaporize a pre-determined amount of the agent for pulmonary delivery thereof is provided herein, as well as devices for effecting vaporization and pulmonary delivery of the isolated agent, and methods for preparing the dose unit, controllably releasing the agent therefrom, methods for pulmonary delivery thereof and methods of treatment of medical conditions treatable by pulmonary delivery of the isolated bioactive agent.
    Type: Application
    Filed: August 6, 2018
    Publication date: December 6, 2018
    Applicant: Syqe Medical Ltd.
    Inventors: Perry DAVIDSON, Aaron SCHORR, Asaf KROLL, Binyamin SCHWARTZ
  • Patent number: 10080851
    Abstract: A dose unit including at least one isolated bioactive agent applied on a carrier material in thermal contact with an electrically heating element configured to vaporize a pre-determined amount of the agent for pulmonary delivery thereof is provided herein, as well as devices for effecting vaporization and pulmonary delivery of the isolated agent, and methods for preparing the dose unit, controllably releasing the agent therefrom, methods for pulmonary delivery thereof and methods of treatment of medical conditions treatable by pulmonary delivery of the isolated bioactive agent.
    Type: Grant
    Filed: December 19, 2016
    Date of Patent: September 25, 2018
    Assignee: Syqe Medical Ltd.
    Inventors: Perry Davidson, Aaron Schorr, Asaf Kroll, Binyamin Schwartz
  • Publication number: 20170136196
    Abstract: A dose unit comprising at least one isolated bioactive agent applied on a carrier material in thermal contact with an electrically heating element configured to vaporize a pre-determined amount of the agent for pulmonary delivery thereof is provided herein, as well as devices for effecting vaporization and pulmonary delivery of the isolated agent, and methods for preparing the dose unit, controllably releasing the agent therefrom, methods for pulmonary delivery thereof and methods of treatment of medical conditions treatable by pulmonary delivery of the isolated bioactive agent.
    Type: Application
    Filed: December 19, 2016
    Publication date: May 18, 2017
    Inventors: Perry DAVIDSON, Aaron SCHORR, Asaf KROLL, Binyamin SCHWARTZ